AU2003268180A1 - Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix - Google Patents
Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ixInfo
- Publication number
- AU2003268180A1 AU2003268180A1 AU2003268180A AU2003268180A AU2003268180A1 AU 2003268180 A1 AU2003268180 A1 AU 2003268180A1 AU 2003268180 A AU2003268180 A AU 2003268180A AU 2003268180 A AU2003268180 A AU 2003268180A AU 2003268180 A1 AU2003268180 A1 AU 2003268180A1
- Authority
- AU
- Australia
- Prior art keywords
- tumor
- therapy
- expression
- compositions
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40557702P | 2002-08-23 | 2002-08-23 | |
US60/405,577 | 2002-08-23 | ||
US64693403A | 2003-08-22 | 2003-08-22 | |
US10/646,934 | 2003-08-22 | ||
PCT/US2003/026612 WO2004017923A2 (en) | 2002-08-23 | 2003-08-25 | Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003268180A1 true AU2003268180A1 (en) | 2004-03-11 |
AU2003268180A8 AU2003268180A8 (en) | 2004-03-11 |
Family
ID=31949897
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003268180A Abandoned AU2003268180A1 (en) | 2002-08-23 | 2003-08-25 | Compositions and methods of therapy for cancers characterized by expression of the tumor-associated antigen mn/ca ix |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1576010A4 (en) |
JP (1) | JP2005536220A (en) |
AU (1) | AU2003268180A1 (en) |
CA (1) | CA2496572A1 (en) |
WO (1) | WO2004017923A2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUE036891T2 (en) | 2002-02-21 | 2018-08-28 | Inst Virology | Mn/ca ix-specific monoclonal antibodies generated from mn/ca ix-deficient mice and methods of use |
US7833734B2 (en) | 2002-11-26 | 2010-11-16 | Institute Of Virology Of The Slovak Academy Of Sciences | CA IX-specific inhibitors |
DOP2006000277A (en) * | 2005-12-12 | 2007-08-31 | Bayer Pharmaceuticals Corp | ANTI MN ANTIBODIES AND METHODS FOR USE |
WO2008091798A2 (en) * | 2007-01-22 | 2008-07-31 | Xencor, Inc. | Optimized ca9 antibodies and methods of using the same |
US20110015158A1 (en) * | 2007-12-11 | 2011-01-20 | Viamet Pharmaceuticals, Inc. | Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties |
CA3139278A1 (en) * | 2019-05-06 | 2020-11-12 | Navi Bio-Therapeutics, Inc. | Anti-carbonic anhydrase ix antibody |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5955075A (en) * | 1992-03-11 | 1999-09-21 | Institute Of Virology, Slovak Academy Of Sciences | Method of inhibiting tumor growth using antibodies to MN protein |
ES2296412T3 (en) * | 1998-10-23 | 2008-04-16 | Institute Of Virology | GEN AND PROTEIN MN. |
-
2003
- 2003-08-25 WO PCT/US2003/026612 patent/WO2004017923A2/en active Application Filing
- 2003-08-25 AU AU2003268180A patent/AU2003268180A1/en not_active Abandoned
- 2003-08-25 EP EP03749129A patent/EP1576010A4/en not_active Withdrawn
- 2003-08-25 JP JP2004531195A patent/JP2005536220A/en not_active Withdrawn
- 2003-08-25 CA CA002496572A patent/CA2496572A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2005536220A (en) | 2005-12-02 |
EP1576010A2 (en) | 2005-09-21 |
EP1576010A4 (en) | 2006-12-27 |
CA2496572A1 (en) | 2004-03-04 |
WO2004017923A2 (en) | 2004-03-04 |
AU2003268180A8 (en) | 2004-03-11 |
WO2004017923A3 (en) | 2005-07-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003302892A1 (en) | Compositions and methods for the therapy and diagnosis of prostate cancer | |
AU2001265296A1 (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
WO2003073826A8 (en) | Novel compositions and methods for cancer | |
AU2002251841A1 (en) | Compositions and methods for the therapy and diagnosis of pancreatic cancer | |
WO2004030615A8 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
WO2004016225A8 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
EP1571968A3 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
WO2004045516A9 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
AU2003293194A1 (en) | Compositions and methods for treating prostate cancer | |
AU2003230750A1 (en) | Compositions and methods for treating cancer | |
AU2002251844A1 (en) | Compositions and methods for the therapy and diagnosis of colon cancer | |
EP1572091A3 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
AU2003224076A1 (en) | Antibody combination useful for tumor therapy | |
WO2004060270A8 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
WO2003057160A8 (en) | Compositions and methods for the diagnosis and treatment of tumor | |
AU2003225535A1 (en) | Methods and compositions for treating cancer | |
AU2002311909A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
WO2003075855A3 (en) | Antibodies against cancer antigen tmeff2 and uses thereof | |
AU2002303219A1 (en) | Compositions and methods for the therapy and diagnosis of cancer | |
AU2002359330A1 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
AU2003299750A1 (en) | Differential tumor cytotoxocity compounds and compositions | |
EP1551388A4 (en) | Compounds useful for the treatment of cancer, compositions thereof and methods therewith | |
AU2002239431A1 (en) | Compositions and methods for the therapy and diagnosis of ovarian cancer | |
AU2003219160A1 (en) | Methods and compositions for the treatment of cancer | |
AU2003223538A1 (en) | Methods for the treatment of cancer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |